Medexus Schedules Third Fiscal Quarter 2023 Conference Call
TORONTO and CHICAGO, Jan. 31, 2023 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday, February 9, 2023 to discuss Medexus’s results for its third fiscal quarter ended December 31, 2022. Medexus expects to file its financial statements and MD&A after markets close on February 8, 2023.
Related news for (MEDXF)
- Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
- Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update
- Medexus Announces New License Deal for Topical Terbinafine
- Medexus Announces US$58.5 million in New Credit Facilities
- Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022